Open Date
-
Close Date
-
Listing Date
-
Price Range
₹0.0 to ₹0.0
IPO Size
₹0.00 Cr
Exchange Symbols
Avience Biomedicals Ltd
Cutoff - Lot Size
Open Date
Close Date
Listing Date
Price Range
IPO Size
Exchange Symbols
Open Date
Close Date
Listing Date
Price Range
IPO Size
Exchange Symbols
Experienced Management Team and trained Employees.
Optimal Utilization of Resources.
Quality assurance and control.
Cordial relationships with our clients.
Recognized under the Make in India Mission initiated by Prime Minister Narendra Modi, The Company commenced its journey by producing essential diagnostic kits like Viral Transport Media (VTM), Covid, HIV, HBs AG, Malaria, Dengue and others aimed at aiding medical institutions with affordable and good quality solutions. Avience Biomedicals has expanded its product range from IVD rapid test kits to include a comprehensive line of medical devices such as Serology products, Biochemistry Analyser and Biochemistry Reagents, showcasing a dedication to addressing various healthcare needs.
Company Name | Avience Biomedicals Ltd |
Headquarter | Delhi |
info@avienbio.com | |
Website | www.avienbio.com |
Skyline Financial Services Pvt
Phone Number | 91-11-26812682 |
Email ID | admin@skylinerta.com/virenr@skylinerta.com |
Website | www.skylinerta.com |
Initial public offer of up to 17,28,000 equity shares of face value of Rs. 10/- each ("The Equity Shares") of Avience Biomedicals Limited ("The Company" or "ABL" or The "Issuer") at an issue price of Rs. [*] per equity share for cash, aggregating up to Rs. [*] crores ("Public Issue") out of which 88,000 equity shares of face value of Rs. 10/- each, at an issue price of Rs. [*] per equity share for cash, aggregating Rs. [*] crores will be reserved for subscription by the market maker to the issue (The "Market Maker Reservation Portion"). The public issue less market maker reservation portion i.e. issue of 16,40,000 equity shares of face value of Rs. 10/- each, at an issue price of Rs. [*] per equity share for cash, aggregating upto Rs. [*] crores is herein after referred to as the "Net Issue". The public issue and net issue will constitute [*] and [*] % respectively of the post-issue paid-up equity share capital of the company. The price band and the minimum bid lot will be decided by the company.
Address: C-11 Block-C Community Cemtre, Janakpuri A-3, Delhi, Delhi, 110058
Phone: 1800-12-04-636
Email: info@avienbio.com
Website: www.avienbio.com
Open Date: -
Close Date: -
Issue Price: ₹
Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.
Congratulations,
Your Digital savings bank account opening journey is complete.